Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Cancer Nursing|October 10, 2009
Differences in symptom clusters identified using occurrence rates versus symptom severity ratings in patients at the end of radiation therapyEsther Kim, Thierry Jahan, Bradley E Aouizerat, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 27, 2009
Changes in symptom clusters in patients undergoing radiation therapyEsther Kim, Thierry Jahan, Bradley E Aouizerat, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesotheliomaRaffit Hassan, Hedy L Kindler, Thierry Jahan, et al.Lung Cancer (Amsterdam, Netherlands)|July 20, 2012
A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancerChristelle Clément-Duchêne, Ronald B Natale, Thierry Jahan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor MalignanciesRahul Aggarwal, Scott Thomas, Nela Pawlowska, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2018
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice GuidelineHedy L Kindler, Nofisat Ismaila, Samuel G Armato, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non-small-cell lung cancerD Ross Camidge, Eamon M Berge, Robert C Doebele, et al.European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|October 17, 2018
Distinct attentional function profiles in older adults receiving cancer chemotherapyInger Utne, Borghild Løyland, Ellen Karine Grov, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomasMiguel Taron, Yukito Ichinose, Rafael Rosell, et al.Journal of Thoracic Disease|November 21, 2013
VATS lobectomy facilitates the delivery of adjuvant docetaxel-carboplatin chemotherapy in patients with non-small cell lung cancerXiuyi Zhi, Wen Gao, Baohui Han, et al.Pageof 3